Page 151 - Syndipharma
P. 151

Sobhan Darou Pharmaceutical Co.

            IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY




                  Founded:                    1976


                  HQ Office:                   No. 295, West Dr. Fatemi Ave, Tehran- IRAN



                  Plant Location:             Sanat3 St., 3 St., Sanat 2 Blv, Industrial City of Rasht
                                                        th

                  Capital:                    13 Million USD



                  Major Shareholder:          Sobhan pharma group


                  Employees:                  190 Persons


                  Company Profile:
                  Sobhan Darou is one of the most successful companies in Iran pharmaceutical market with more than 140 product
                  licenses. Sobhan Darou manufactures and supplies high quality products for medical needs and social responsibil-
                  ity in order to promote the health and vitality of society and protecting the environment in the best possible way.
                  The major activities of Sobhan Darou are production and packaging of various type of pharmaceutical products.
                  Sobhan Darou gets the position as the first manufacturer of pharmaceutical products in Iran (number of units sold
                  per year), and the most famous domestic manufacturer of CNS drugs.
                  Sobhan Darou has GMP certificate from Iran FDA .
                  Sobhan Darou has a fully equipped central laboratory that is responsible for sampling, testing against approved
                  specifications according to the relevant SOPs and has the accreditation certificate from Iran FDA.


                  Production Lines:
                  Solid production lines:  The solid manufacturing site has established on an area about 4350 square meters. The
                  Solid production annual capacity is more than 2.5 billion tablets and 150 million capsules.
                  Semi Solid production lines: The Semi-Solid manufacturing new site is built in 2016. It has established on an area
                  about 1900 square meters. Semisolid production capacity is approximately 15 million tubes annually.




                  Premier partners:
                  ABC Farmaceutici- Italy (under-license manufacturing)
                  Adamed- Poland (under-license manufacturing)
                  Waypharm- Germany (know-how transfer)
                  Apotex- Canada (contract manufacturing)



                  Target Countries for Exports:
                  Iraq- Kazakhstan- Syria- Afghanistan- Lebanon











          150
   146   147   148   149   150   151   152   153   154   155   156